Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis

Neuropharmacology

Volumn 56, Issue SUPPL. 1, 2009, Pages 122-132

  Carlezon Jr , William A ^a   Thomas, Mark J ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Addiction; Behavior; Electrophysiology; Model; Molecular biology

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DOPAMINE; GLUTAMIC ACID;

ADDICTION; AMYGDALOID NUCLEUS; AVERSION; HIPPOCAMPUS; HUMAN; MOOD; MOTIVATION; NEUROBIOLOGY; NEUROPSYCHOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; REWARD; VENTRAL TEGMENTUM;

ANIMALS; AVOIDANCE LEARNING; NUCLEUS ACCUMBENS; REWARD; STREET DRUGS;

EID: 58049180709     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.06.075     Document Type: Review

References (131)

1. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276 (1978) 186-188
2. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 (1989) 366-375
3. Bals-Kubik R., Ableitner A., Herz A., and Shippenberg T.S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264 (1993) 489-495
4. Benavides D.R., Quinn J.J., Zhong P., Hawasli A.H., DiLeone R.J., Kansy J.W., Olausson P., Yan Z., Taylor J.R., and Bibb J.A. Cdk5 modulates cocaine reward, motivation, and striatal neuron excitability. J. Neurosci. 27 (2007) 12967-12976
5. Bodnar R.J., Glass M.J., Ragnauth A., and Cooper M.L. General, mu and kappa opioid antagonists in the nucleus accumbens alter food intake under deprivation, glucoprivic and palatable conditions. Brain Res. 700 (1995) 205-212
6. Bozarth M.A., and Wise R. Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci. 28 (1981) 551-555
7. Bozarth M.A., and Wise R.A. Neural substrates of opiate reinforcement. Prog. Neuropsychopharmacol. Biol. Psychiatr. 7 (1983) 569-575
8. Caine S.B., Negus S.S., Mello N.K., and Bergman J. Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J. Pharmacol. Exp. Ther. 291 (1999) 353-360
9. Caine S.B., Negus S.S., and Mello N.K. Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology 148 (2000) 41-51
10. Carelli R.M., Ijames S.G., and Crumling A.J. Evidence that separate neural circuits in the nucleus accumbens encode cocaine versus "natural" (water and food) reward. J. Neurosci. 20 (2000) 4255-4266
11. Carlezon W.A., and Nestler E.J. Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse?. Trends Neurosci. 25 (2002) 610-615
12. Carlezon W.A., and Wise R.A. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J. Neurosci. 16 (1996) 3112-3122
13. Carlezon W.A., Devine D.P., and Wise R.A. Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology 122 (1995) 194-197
14. Carlezon W.A., Boundy V.A., Haile C.N., Lane S.B., Kalb R.G., Neve R.L., and Nestler E.J. Sensitization to morphine induced by viral-mediated gene transfer. Science 277 (1997) 812-814
15. Carlezon W.A., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., and Nestler E.J. Regulation of cocaine reward by CREB. Science 282 (1998) 2272-2275
16. Carlezon W.A., Duman R.S., and Nestler E.J. The many faces of CREB. Trends Neurosci. 28 (2005) 436-445
17. Carlezon W.A., Beguin C., DiNieri J.A., Baumann M.H., Richards M.R., Todtenkopf M.S., Rothman R.B., Ma Z., Lee D.Y., and Cohen B.M. Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J. Pharmacol. Exp. Ther. 316 (2006) 440-447
18. Chang J.Y., Zhang L., Janak P.H., and Woodward D.J. Neuronal responses in prefrontal cortex and nucleus accumbens during heroin self-administration in freely moving rats. Brain Res. 754 (1997) 12-20
19. Chao S.Z., Ariano M.A., Peterson D.A., and Wolf M.E. D1 dopamine receptor stimulation increases GluR1 surface expression in nucleus accumbens neurons. J. Neurochem. 83 (2002) 704-712
20. Chartoff E.H., Mague S.D., Barhight M.F., Smith A.M., and Carlezon Jr. W.A. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J. Neurosci. 26 (2006) 6450-6457
21. Chartoff E.H., Pliakas A.M., and Carlezon Jr. W.A. Microinjection of the L-type calcium channel antagonist diltiazem into the ventral nucleus accumbens shell facilitates cocaine-induced conditioned place preferences. Biol. Psychiatr. 59 (2006) 1236-1239
22. Cheer J.F., Aragona B.J., Heien M.L., Seipel A.T., Carelli R.M., and Wightman R.M. Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron 54 (2007) 237-244
23. Cheer J.F., Heien M.L., Garris P.A., Carelli R.M., and Wightman R.M. Simultaneous dopamine and single-unit recordings reveal accumbens GABAergic responses: implications for intracranial self-stimulation. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 19150-19155
24. Chen, M.C., Parsegian, A., Carlezon Jr., W.A., 2008. Effect of mesocorticolimbic microinjections of the kappa-opioid agonist U50,488 on intracranial self-stimulation in rats. Soc. Neurosci. Abstr. 34, in press.
25. Childress A.R. What can human brain imaging tell us about the vulnerability to addiction and to relapse?. In: Miller W.R., and Carroll K.M. (Eds). Rethinking Substance Abuse: What the Science Shows and What we should do about it (2006), Guilford, New York 46-60
26. Churchill L., Swanson C.J., Urbina M., and Kalivas P.W. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J. Neurochem. 72 (1999) 2397-2403
27. Cooper D.C., and White F.J. L-type calcium channels modulate glutamate-driven bursting activity in the nucleus accumbens in vivo. Brain Res. 880 (2000) 212-218
28. de Rover M., Lodder J.C., Kits K.S., Schoffelmeer A.N., and Brussaard A.B. Cholinergic modulation of nucleus accumbens medium spiny neurons. Eur. J. Neurosci. 16 (2002) 2279-2290
29. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 5274-5278
30. DiNieri J.A., Carle T., Nestler E.J., and Carlezon Jr. W.A. Inducible disruption of CREB activity within nucleus accumbens alters sensitivity to rewarding and prodepressive drugs. Soc. Neurosci. Abstr. 32 (2006)
31. Dong Y., Saal D., Thomas M., Faust R., Bonci A., Robinson T., and Malenka R.C. Cocaine-induced potentiation of synaptic strength in dopamine neurons: behavioral correlates in GluRA(-/-) mice. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14282-14287
32. Dong Y., Green T., Saal D., Marie H., Neve R., Nestler E.J., and Malenka R.C. CREB modulates excitability of nucleus accumbens neurons. Nat. Neurosci. 9 (2006) 475-477
33. Donzanti B.A., Althaus J.S., Payson M.M., and Von Voigtlander P.F. Kappa agonist-induced reduction in dopamine release: site of action and tolerance. Res. Commun. Chem. Pathol. Pharmacol. 78 (1992) 193-210
34. Dunn A.J. Stress-related activation of cerebral dopaminergic systems. Ann. N.Y. Acad. Sci. 537 (1988) 188-205
35. Elmer G.I., Pieper J.O., Levy J., Rubinstein M., Low M.J., Grandy D.K., and Wise R.A. Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Psychopharmacology 182 (2005) 33-44
36. Fibiger H.C., Nomikos G.G., Pfaus J.G., and Damsma G. Sexual behavior, eating and mesolimbic dopamine. Clin. Neuropharmacol. 15 Suppl. 1 (1992) 566A-567A
37. Finlay J.M., Damsma G., and Fibiger H.C. Benzodiazepine-induced decreases in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration. Psychopharmacology 106 (1992) 202-208
38. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., and Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990) 1429-1432
39. Goeders N.E., and Smith J.E. Cortical dopaminergic involvement in cocaine reinforcement. Science 221 (1983) 773-775
40. Gong S., Zheng C., Doughty M.L., Losos K., Didkovsky N., Schambra U.B., Nowak N.J., Joyner A., Leblanc G., Hatten M.E., and Heintz N. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425 (2003) 917-925
41. Grace A.A., Floresco S.B., Goto Y., and Lodge D.J. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci. 30 (2007) 220-227
42. Gracy K.N., Dankiewicz L.A., and Koob G.F. Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24 (2001) 152-160
43. Griffiths R.R., and Ator N.A. Benzodiazepine self-administration in animals and humans: a comprehensive literature review. NIDA Res. Monogr. 33 (1980) 22-36
44. Guix T., Hurd Y.L., and Ungerstedt U. Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats. Neurosci. Lett. 138 (1992) 137-140
45. Hakan R.L., and Henriksen S.J. Opiate influences on nucleus accumbens neuronal electrophysiology: dopamine and non-dopamine mechanisms. J. Neurosci. 9 (1989) 3538-3546
46. Hallett P.J., Spoelgen R., Hyman B.T., Standaert D.G., and Dunah A.W. Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking. J. Neurosci. 26 (2006) 4690-4700
47. Harris G.C., and Aston-Jones G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371 (1994) 155-157
48. Herman J.P., Rivet J.M., Abrous N., and Le Moal M. Intracerebral dopaminergic transplants are not activated by electrical footshock stress activating in situ mesocorticolimbic neurons. Neurosci. Lett. 90 (1988) 83-88
49. Hoebel B.G., Monaco A.P., Hernandez L., Aulisi E.F., Stanley B.G., and Lenard L. Self-injection of amphetamine directly into the brain. Psychopharmacology 81 (1983) 158-163
50. 2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252 (1991) 851-853
51. + channels in rat nucleus accumbens neurons. J. Neurophysiol. 92 (2004) 1597-1607
52. Ikemoto I. Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies. J. Neurosci. 23 (2003) 9305-9311
53. Ikemoto S., Glazier B.S., Murphy J.M., and McBride W.J. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J. Neurosci. 17 (1997) 8580-8587
54. Imperato A., Obinu M.C., Demontis M.V., and Gessa G.L. Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors. Eur. J. Pharmacol. 229 (1992) 265-267
55. Janak P.H., Chang J.Y., and Woodward D.J. Neuronal spike activity in the nucleus accumbens of behaving rats during ethanol self-administration. Brain Res. 817 (1999) 172-184
56. Johnson S.W., and North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12 (1992) 483-488
57. Kalivas P.W., and Duffy P. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol. Psychiatr. 25 (1989) 913-928
58. Kelley A.E. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci. Biobehav. Rev. 27 (2004) 765-776
59. Kelley A.E., Bless E.P., and Swanson C.J. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats. J. Pharmacol. Exp. Ther. 278 (1996) 1499-1507
60. Kelsey J.E., Carlezon W.A., and Falls W.A. Lesions of the nucleus accumbens in rats reduce opiate reward but do not alter context-specific opiate tolerance. Behav. Neurosci. 103 (1989) 1327-1334
61. Kelz M.B., Chen J., Carlezon W.A., Whisler K., Gilden L., Beckmann A.M., Steffen C., Zhang Y.J., Marotti L., Self D.W., Tkatch T., Baranauskas G., Surmeier D.J., Neve R.L., Duman R.S., Picciotto M.R., and Nestler E.J. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401 (1999) 272-276
62. Kessler R.C., Zhao S., Blazer D.G., and Swartz M. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J. Affect. Disord. 45 (1997) 19-30
63. Kourrich S., Rothwell P.E., Klug J.R., and Thomas M.J. Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens. J. Neurosci. 27 (2007) 7921-7928
64. Leone P., Pocock D., and Wise R.A. Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol. Biochem. Behav. 39 (1991) 469-472
65. Liu, Z.H., Shin, R., Ikemoto, S. Dual role of medial A10 dopamine neurons in affective encoding. Neuropsychopharmacol, in press.
66. Lobo M.K., Karsten S.L., Gray M., Geschwind D.H., and Yang X.W. FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nat. Neurosci. 9 (2006) 443-452
67. Mague S.D., Pliakas A.M., Todtenkopf M.S., Tomasiewicz H.C., Zhang Y., Stevens W.C., Jones R.M., Portoghese P.S., and Carlezon Jr. W.A. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther. 305 (2003) 323-330
68. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., and Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 388 (1997) 586-589
69. Malinow R., and Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 25 (2002) 103-126
70. Mangiavacchi S., and Wolf M.E. D1 dopamine receptor stimulation increases the rate of AMPA receptor insertion onto the surface of cultured nucleus accumbens neurons through a pathway dependent on protein kinase A. J. Neurochem. 88 (2004) 1261-1271
71. Mansour A., Watson S.J., and Akil H. Opioid receptors: past, present and future. Trends Neurosci. 18 (1995) 69-70
72. Mark G.P., Rada P., Pothos E., and Hoebel B.G. Effects of feeding and drinking on acetylcholine release in the nucleus accumbens, striatum, and hippocampus of freely behaving rats. J. Neurochem. 58 (1992) 2269-2274
73. Markou A., Hauger R.L., and Koob G.F. Desmethylimipramine attenuates cocaine withdrawal in rats. Psychopharmacology 109 (1994) 305-314
74. Mead A.N., Brown G., Le Merrer J., and Stephens D.N. Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice. Psychopharmacology (Berl) 179 (2005) 164-171
75. Mead A.N., Zamanillo D., Becker N., and Stephens D.N. AMPA-receptor GluR1 subunits are involved in the control over behavior by cocaine-paired cues. Neuropsychopharmacology 32 (2007) 343-353
76. McCarthy P.S., Walker R.J., and Woodruff G.N. Depressant actions of enkephalins on neurones in the nucleus accumbens [proceedings]. J. Physiol. 267 (1977) 40P-41P
77. McFarland K., Davidge S.B., Lapish C.C., and Kalivas P.W. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J. Neurosci. 24 (2004) 1551-1560
78. Meredith G.E. The synaptic framework for chemical signaling in nucleus accumbens. Ann. N.Y. Acad. Sci. 877 (1999) 140-156
79. Mizrahi R., Rusjan P., Agid O., Graff A., Mamo D.C., Zipursky R.B., and Kapur S. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am. J. Psychiatr. 164 (2007) 630-637
80. Murai T., Koshikawa N., Kanayama T., Takada K., Tomiyama K., and Kobayashi M. Opposite effects of midazolam and beta-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur. J. Pharmacol. 261 (1994) 65-71
81. Nestler E.J., and Carlezon Jr. W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatr. 59 (2006) 1151-1159
82. Newton S.S., Thome J., Wallace T.L., Shirayama Y., Schlesinger L., Sakai N., Chen J., Neve R., Nestler E.J., and Duman R.S. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 22 (2002) 10883-10890
83. Nicola S.M., Surmeier J., and Malenka R.C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev. Neurosci. 23 (2000) 185-215
84. Nicola S.M., Yun I.A., Wakabayashi K.T., and Fields H.L. Firing of nucleus accumbens neurons during the consummatory phase of a discriminative stimulus task depends on previous reward predictive cues. J. Neurophysiol. 91 (2004) 1866-1882
85. O'Donnell P., and Grace A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input. J. Neurosci. 15 (1995) 3622-3639
86. O'Donnell P., and Grace A.A. Dopaminergic reduction of excitability in nucleus accumbens neurons recorded in vitro. Neuropsychopharmacology 15 (1996) 87-97
87. Olds M.E. Reinforcing effects of morphine in the nucleus accumbens. Brain Res. 237 (1982) 429-440
88. Parsegian, A., Todtenkopf, M.S., Neve, R.L., Carlezon Jr., W.A., 2006. Viral vector-induced elevations of CREB expression in the nucleus accumbens produces anhedonia in the rat intracranial self-stimulation (ICSS) test. Soc. Neurosci. Abstr. 32.
89. Pennartz C.M., Boeijinga P.H., and Lopes da Silva F.H. Locally evoked potentials in slices of the rat nucleus accumbens: NMDA and non-NMDA receptor mediated components and modulation by GABA. Brain Res. 529 (1990) 30-41
90. Peoples L.L., and West M.O. Phasic firing of single neurons in the rat nucleus accumbens correlated with the timing of intravenous cocaine self-administration. J. Neurosci. 16 (1996) 3459-3473
91. Peoples L.L., Kravitz A.V., and Guillem K. The role of accumbal hypoactivity in cocaine addiction. ScientificWorldJournal 7 (2007) 22-45
92. Pfaus J.G. Neurobiology of sexual behavior. Curr. Opin. Neurobiol. 9 (1999) 751-758
93. Pfeiffer A., Brantl V., Herz A., and Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science 233 (1986) 774-776
94. Phillips A.G., and LePiane G. Disruption of conditioned taste aversion in the rat by stimulation of amygdale: a conditioning effect, not amnesia. J. Comp. Physiol. Psychol. 94 (1980) 664-674
95. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., and Carlezon Jr. W.A. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21 (2001) 7397-7403
96. Rajadhyaksha A., Barczak A., Macías W., Leveque J.C., Lewis S.E., and Konradi C. L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J. Neurosci. 19 (1999) 6348-6359
97. Roberts D.C., Koob G.F., Klonoff P., and Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12 (1980) 781-787
98. Roitman M.F., Wheeler R.A., and Carelli R.M. Nucleus accumbens neurons are innately tuned for rewarding and aversive taste stimuli, encode their predictors, and are linked to motor output. Neuron 45 (2005) 587-597
99. Smith K.S., and Berridge K.C. Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J. Neurosci. 27 (2007) 1594-1605
100. Snyder G.L., Allen P.B., Fienberg A.A., Valle C.G., Huganir R.L., Nairn A.C., and Greengard P. Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci. 20 (2000) 4480-4488
101. Spanagel R., Herz A., and Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2046-2050
102. Stinus L., Le Moal M., and Koob G.F. Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37 (1990) 767-773
103. Sun X., Milovanovic M., Zhao Y., and Wolf M.E. Acute and chronic dopamine receptor stimulation modulates AMPA receptor trafficking in nucleus accumbens neurons cocultured with prefrontal cortex neurons. J. Neurosci. 28 (2008) 4216-4230
104. Surmeier D.J., Ding J., Day M., Wang Z., and Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci. 30 (2007) 228-235
105. Svingos A.L., Colago E.E., and Pickel V.M. Cellular sites for dynorphin activation of kappa-opioid receptors in the rat nucleus accumbens shell. J. Neurosci. 19 (1999) 1804-1813
106. Swanson G.T., Kamboj S.K., and Cull-Candy S.G. Single-channel properties of recombinant AMPA receptors depend on RNA editing, splice variation, and subunit composition. J. Neurosci. 17 (1997) 58-69
107. Taha S.A., and Fields H.L. Encoding of palatability and appetitive behaviors by distinct neuronal populations in the nucleus accumbens. J. Neurosci. 25 (2005) 1193-1202
108. Tindell A.J., Berridge K.C., and Aldridge J.W. Ventral pallidal representation of pavlovian cues and reward: population and rate codes. J. Neurosci. 24 (2004) 1058-1069
109. Tindell A.J., Smith K.S., Peciña S., Berridge K.C., and Aldridge J.W. Ventral pallidum firing codes hedonic reward: when a bad taste turns good. J. Neurophysiol. 96 (2006) 2399-2409
110. Todtenkopf M.S., and Stellar J.R. Assessment of tyrosine hydroxylase immunoreactive innervation in five subregions of the nucleus accumbens shell in rats treated with repeated cocaine. Synapse 38 (2000) 261-270
111. Todtenkopf M.S., Marcus J.F., Portoghese P.S., and Carlezon Jr. W.A. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats. Psychopharmacology 172 (2004) 463-470
112. Todtenkopf M.S., Parsegian A., Naydenov A., Neve R.L., Konradi C., and Carlezon Jr. W.A. Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell. J. Neurosci. 26 (2006) 11665-11669
113. Trujillo K.A., Belluzzi J.D., and Stein L. Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit. Brain Res. 492 (1989) 15-28
114. Turgeon S.M., Pollack A.E., and Fink J.S. Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res. 749 (1997) 120-126
115. Uchimura N., Higashi H., and Nishi S. Membrane properties and synaptic responses of the guinea pig nucleus accumbens neurons in vitro. J. Neurophysiol. 61 (1989) 769-779
116. Vekovischeva O.Y., Zamanillo D., Echenko O., Seppälä T., Uusi-Oukari M., Honkanen A., Seeburg P.H., Sprengel R., and Korpi E.R. Morphine-induced dependence and sensitization are altered in mice deficient in AMPA-type glutamate receptor-A subunits. J. Neurosci. 21 (2001) 4451-4459
117. Volkow N.D., Fowler J.S., Wang G.J., Swanson J.M., and Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch. Neurol. 64 (2007) 1575-1579
118. Wadenberg M.L. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist. CNS Drug Rev. 9 (2003) 187-198
119. Weiss R.D. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction 99 (2004) 1382-1392
120. Welter M., Vallone D., Samad T.A., Meziane H., Usiello A., and Borrelli E. Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 6840-6845
121. West T.E., and Wise R.A. Effects of naltrexone on nucleus accumbens, lateral hypothalamic and ventral tegmental self-stimulation rate-frequency functions. Brain Res. 462 (1988) 126-133
122. Wheeler R.A., Twining R.C., Jones J.L., Slater J.M., Grigson P.S., and Carelli R.M. Behavioral and electrophysiological indices of negative affect predict cocaine self-administration. Neuron 57 (2008) 774-785
123. Wise R.A. Neuroleptics and operant behavior: the anhedonia hypothesis. Behav. Brain Sci. 5 (1982) 39-87
124. Wise R.A. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 19 (1996) 319-340
125. Wise R.A., and Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94 (1987) 469-492
126. Wise R.A., and Rompré P.P. Brain dopamine and reward. Annu. Rev. Psychol. 40 (1989) 191-225
127. Wood P.L. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat. J. Pharmacol. Exp. Ther. 222 (1982) 674-679
128. Yun I.A., Wakabayashi K.T., Fields H.L., and Nicola S.M. The ventral tegmental area is required for the behavioral and nucleus accumbens neuronal firing responses to incentive cues. J. Neurosci. 24 (2004) 2923-2933
129. Yun I.A., Nicola S.M., and Fields H.L. Contrasting effects of dopamine and glutamate receptor antagonist injection in the nucleus accumbens suggest a neural mechanism underlying cue-evoked goal-directed behavior. Eur. J. Neurosci. 20 (2004) 249-263
130. Zahm D.S. Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Ann. N.Y. Acad. Sci. 877 (1999) 113-128
131. Zhang X.F., Hu X.T., and White F.J. Whole-cell plasticity in cocaine withdrawal: reduced sodium currents in nucleus accumbens neurons. J. Neurosci. 18 (1998) 488-498